Context Therapeutics
Context Therapeutics add new CMO
July 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Context Therapeutics, biotech, drugs, pharma, pharmaceutical
Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
